These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 220644)

  • 21. The role of insulin-sensitive phosphodiesterase in insulin action.
    Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
    Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
    Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER
    J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depolarization counteracts glucocorticoid inhibition of adenohypophysical corticotroph cells.
    Lim MC; Shipston MJ; Antoni FA
    Br J Pharmacol; 1998 Aug; 124(8):1735-43. PubMed ID: 9756391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
    J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs.
    Kapui Z; Schaeffer P; Mikus EG; Boronkay E; Gyürky J; Herbert JM; Pascal M
    Arzneimittelforschung; 1999 Aug; 49(8):685-93. PubMed ID: 10483515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terferol, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I. Isolation and characterization.
    Nakagawa F; Enokita R; Naito A; Iijima Y; Yamazaki M
    J Antibiot (Tokyo); 1984 Jan; 37(1):6-9. PubMed ID: 6321424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of psychotropic preparations on cyclic AMP phosphodiesterase activity in the rat cerebral cortex].
    Shchekoldina TG; Vatolkina OE; Libinzon RE
    Vopr Med Khim; 1978; 24(2):166-9. PubMed ID: 208286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro inhibition of cyclic AMP phosphodiesterase by cortisol.
    Schmidtke J; Wienker T; Flügel M; Engel W
    Nature; 1976 Aug; 262(5569):593-4. PubMed ID: 183135
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of the role of endogenous 3',5'-cyclic AMP in the radioresistance of the cell].
    Shivotova NI; Filippovich IV; Romantsev EF
    Vopr Med Khim; 1976; 22(4):533-8. PubMed ID: 194414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by nicotinic acid [proceedings].
    Saeed SA; Butt NM; Lovely JR; Collier HO
    Biochem Soc Trans; 1979 Oct; 7(5):1042-4. PubMed ID: 229022
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence that the peripheral cyclic AMP phosphodiesterase of rat liver plasma membranes is a metalloenzyme.
    Londesborough J
    Biochem J; 1985 Jan; 225(1):143-7. PubMed ID: 2983659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acylpeptides, the inhibitors of cyclic adenosine 3',5'-monophosphate phosphodiesterase. III. Inhibition of cyclic AMP phosphodiesterase.
    Hosono K; Suzuki H
    J Antibiot (Tokyo); 1983 Jun; 36(6):679-83. PubMed ID: 6307959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of a high molecular weight cyclic 3',5'-nucleotide phosphodiesterase isolated from rat liver.
    Rhoads AR; Olowofoyeku AK; West WL; Morris HP
    Biochem Pharmacol; 1976 Jan; 25(1):97-9. PubMed ID: 175802
    [No Abstract]   [Full Text] [Related]  

  • 34. The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
    Larsson PG; Haffner F; Brłnstad GO; Christoffersen T
    Br J Cancer; 1979 Nov; 40(5):768-73. PubMed ID: 228692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties and characterization of low molecular weight inhibitor of calmodulin-dependent cAMP phosphodiesterase from rat liver.
    Rao RH; Palazzolo M; Sanders L; Smoake JA; Solomon SS
    Life Sci; 1984 Nov; 35(21):2155-64. PubMed ID: 6092816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concanavalin A ibhibition of liver plasma membrane-bound cyclic AMP-phosphodiesterase.
    Luly P; Scapin S; Ferretti E; Tomasi V
    FEBS Lett; 1976 Apr; 64(1):209-13. PubMed ID: 178544
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of cAMP phosphodiesterase by some phototherapeutic agents.
    Bovalini L; Lusini P; Simoni S; Vedaldi D; Andreassi L; Dall'Acqua F; Martelli P
    Z Naturforsch C J Biosci; 1987; 42(7-8):1009-10. PubMed ID: 2825441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,4-Diamino-5-cyano-6-halopyridines: a new class of cyclic AMP phosphodiesterase inhibitors with therapeutic potential.
    de Haën C; Nist BJ; Hansen RS; Johnson DG; Thompson WJ
    Biochem Pharmacol; 1984 Jul; 33(13):2109-13. PubMed ID: 6331459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by colchicine: implications for glucagon and corticosteroid secretion.
    Ewart R; Bradford M
    Life Sci; 1988; 42(25):2587-92. PubMed ID: 2838708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased cyclic AMP-phosphodiesterase activity during inflammation and its inhibition by anti-inflammatory drugs.
    Naik SR
    Eur J Pharmacol; 1984 Sep; 104(3-4):253-9. PubMed ID: 6094215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.